Search

everythinglearnresearchcommunity

for

Search:↓

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone helps regrow hair in women with hair loss.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Minoxidil can reduce functions related to androgen receptors.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.